/DaVita%20Inc%20sign%20on%20building-by%20photo-denver%20via%20Shutterstock.jpg)
DaVita is all set to release its third-quarter earnings this month, and analysts expect a single-digit profit dip.
/Henry%20Schein%20Inc_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shuttestock.jpg)
Henry Schein outperformed its industry peers recently, and Wall Street analysts remain moderately optimistic about the stock’s prospects.
/Labcorp%20Holdings%20Inc_%20location-by%20Sundry%20Photography%20via%20iStock.jpg)
Labcorp Holdings recently outperformed the healthcare sector peers, and Wall Street analysts are moderately optimistic about the stock’s prospects.
/HCA%20Healthcare%20Inc%20sign%20on%20building-by%20JHVEPhoto%20via%20Shutterstock.jpg)
HCA Healthcare has significantly outperformed the broader market this year, and Wall Street analysts are bullish about the stock’s prospects.
/Universal%20Health%20Services%2C%20Inc_%20logo%20on%20phone-by%20IgorGolovniov%20via%20Shutterstock.jpg)
Despite Universal Health Services’ outperformance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Quest%20Diagnostics%2C%20Inc_%20logo%20on%20building-by%20Tada%20Images%20via%20Shutterstock.jpg)
As Quest Diagnostics underperformed relative to the S&P 500 Index over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
/Humana%20Inc_%20logo%20on%20laptop-by%20monticello%20via%20Shutterstock.jpg)
Despite Humana underperforming the broader market over the past year, Wall Street analysts remain moderately bullish on the stock’s prospects.
/Henry%20Schein%20Inc_%20sign%20outside%20office-by%20JHVEPhoto%20via%20Shutterstock.jpg)
As Henry Schein underperformed the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.
DaVita has surpassed the broader market over the past year, and Wall Street analysts are cautious about the stock’s prospects.
/Cardinal%20Health%2C%20Inc_%20magnified-by%20Casimiro%20PT%20via%20Shutterstock.jpg)
Cardinal Health has underperformed the broader market over the past year, but Wall Street analysts are moderately bullish about the stock’s prospects.